Demonstration venue · read-only. Every page can be browsed; the buttons that would change it are switched off. Create an account to run TaxoReview on your own data. A simulation from public publication records: the people listed were not invited and did not agree to review.
? Tutorial for this page

Gregory M. Riedlinger

dblp:243/8951 · DBLP profile ↗
← Back
3ranked-venue papers
0as first author
0since 2021 · last 2020
0000-0001-5690-7777ORCID · reported

Domains — the database's venue-derived domains; a paper can count in several

Applied, interdisciplinary, general and emerging computing · 3Graphics, computer vision, multimedia, augmented reality and games · 1

Expertise — from the expertise taxonomy: the topics of the expert's papers under the CCF categories. A weight counts papers with recency: 1 for a paper about the topic, 0.3 when the topic is its context, halved every five years.

Interdisciplinary, comprehensive, and emerging computing
1 paper
Bioinformatics and computational biology · 100%

Topics — the 2 heaviest of 2, each with the papers that count most for it

TopicWeightPapersLastEvidence papers
Bioinformatics and computational biology
cancer genomics
0.412020
All-FIT: allele-frequency-based imputation of tumor purity from high-depth sequencing data · Bioinform. 2020
Bioinformatics and computational biology › cancer genomics
tumor purity estimation
0.412020
All-FIT: allele-frequency-based imputation of tumor purity from high-depth sequencing data · Bioinform. 2020

Methods — techniques the papers use, named apart from their topics

iterative weighted least-squares · 0.4high-depth sequencing · 0.4
YearPublicationVenuePosition
2020 All-FIT: allele-frequency-based imputation of tumor purity from high-depth sequencing data
abstract
SUMMARY: Clinical sequencing aims to identify somatic mutations in cancer cells for accurate diagnosis and treatment. However, most widely used clinical assays lack patient-matched control DNA and additional analysis is needed to distinguish somatic and unfiltered germline variants. Such computational analyses require accurate assessment of tumor cell content in individual specimens. Histological estimates often do not corroborate with results from computational methods that are primarily designed for normal-tumor matched data and can be confounded by genomic heterogeneity and presence of sub-clonal mutations. Allele-frequency-based imputation of tumor (All-FIT) is an iterative weighted least square method to estimate specimen tumor purity based on the allele frequencies of variants detected in high-depth, targeted, clinical sequencing data. Using simulated and clinical data, we demonstrate All-FIT's accuracy and improved performance against leading computational approaches, highlighting the importance of interpreting purity estimates based on expected biology of tumors. AVAILABILITY AND IMPLEMENTATION: Freely available at http://software.khiabanian-lab.org. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online.
Jui Wan Loh, Caitlin Guccione, Frances Di Clemente, Gregory M. Riedlinger, Shridar Ganesan, Hossein Khiabanian
Bioinform.4
2020 Weakly Supervised Deep Nuclei Segmentation Using Partial Points Annotation in Histopathology Images
abstract
Nuclei segmentation is a fundamental task in histopathology image analysis. Typically, such segmentation tasks require significant effort to manually generate accurate pixel-wise annotations for fully supervised training. To alleviate such tedious and manual effort, in this paper we propose a novel weakly supervised segmentation framework based on partial points annotation, i.e., only a small portion of nuclei locations in each image are labeled. The framework consists of two learning stages. In the first stage, we design a semi-supervised strategy to learn a detection model from partially labeled nuclei locations. Specifically, an extended Gaussian mask is designed to train an initial model with partially labeled data. Then, self-training with background propagation is proposed to make use of the unlabeled regions to boost nuclei detection and suppress false positives. In the second stage, a segmentation model is trained from the detected nuclei locations in a weakly-supervised fashion. Two types of coarse labels with complementary information are derived from the detected points and are then utilized to train a deep neural network. The fully-connected conditional random field loss is utilized in training to further refine the model without introducing extra computational complexity during inference. The proposed method is extensively evaluated on two nuclei segmentation datasets. The experimental results demonstrate that our method can achieve competitive performance compared to the fully supervised counterpart and the state-of-the-art methods while requiring significantly less annotation effort.
Pengxiang Wu, Qiaoying Huang, Jingru Yi, Zhennan Yan, Kang Li 0004, Gregory M. Riedlinger, Subhajyoti De, Shaoting Zhang 0001, Dimitris N. Metaxas
IEEE Trans. Medical Imaging7
2019 Improving Nuclei/Gland Instance Segmentation in Histopathology Images by Full Resolution Neural Network and Spatial Constrained Loss
Zhennan Yan, Gregory M. Riedlinger, Subhajyoti De, Dimitris N. Metaxas
MICCAI (1)3